Journal of radiological science and technology (대한방사선기술학회지:방사선기술과학)

Korean Society of Radiological Science (대한방사선과학회)
권호 표지
DOI QR코드

DOI QR Code

Analysis on Usefulness of Non-invasive Liver Fibrosis Evaluation Method according to the Liver Disease : Focused on Hepatitis C patients

간질환 종류에 따른 비침습적 간섬유화 평가법의 유용성 분석 : C형 간염 보균자 중심으로

  • Nam, Ji-Hee (Department of Radiology of Busan Paik Hospital) ;
  • Kim, Jung-Hoon (Department of Radiological Science, Catholic University of Pusan)
  • 남지희 (인제대학교 부산백병원 영상의학과) ;
  • 김정훈 (부산가톨릭대학교 보건과학대학 방사선학과)
  • Received : 2019.10.07
  • Accepted : 2019.10.22
  • Published : 2019.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Liver biopsy is the gold standard for diagnosing liver fibrosis, but it is invasive and has a risk for complications. For this reason, recently, study has been actively conducted on non-invasive liver fibrosis evaluation method. But, there is no established standard for the type of diffuse liver disease. Therefore, this study was suggest the usefulness and cut-off values of Fibroscan, FIB-4, APRI and AAR of patients with hepatitis C in Korea. According to the diagnosis, 240 people in hepatitis C are classified into fatty liver, chronic hepatitis, and liver cirrhosis. The statistical analysis was performed by ANOVA to verify difference between groups. The ROC curve was analyzed to determine the usefulness and practical cut-off value. As a result, for all diseases, the AUC value for Fibroscan was 0.8 over and the APRI was 0.7 over. Cut-off value of serum based liver fibrosis markers was increased in order of fatty liver, chronic hepatitis and liver cirrhosis. If Fibroscan and serological liver fibrosis markers are applied to predict liver fibrosis, it is expected that excessive liver biopsy can be reduced.

Keywords

References

  1. Statistics Korea. Causes of Death Statistics. Statistics Korea; 2017.
  2. Kim BH, Lim YS, Kim EY, Kong HJ, Won YJ, Han S, et al. Temporal improvement in survival of patients with hepatocellular carcinoma in a hepatitis B virus-endemic population. J Gastroenterol Hepatol. 2018 Feb;33(2):475-83. https://doi.org/10.1111/jgh.13848
  3. Jeong SH, Jang ES, Choi HY, Kim KA, Chung W, Ki M. Current status of hepatitis C virus infection and countermeasures in South Korea. Epidemiol Health. 2017 Apr;39:e2017017. PMC5543292. https://doi.org/10.4178/epih.e2017017
  4. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. J Hepatol. 2003 Aug;38(2):518-26.
  5. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol. 1986;2(2):165-73. https://doi.org/10.1016/S0168-8278(86)80075-7
  6. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002 Oct;97(10):2614-8. https://doi.org/10.1111/j.1572-0241.2002.06038.x
  7. An H, Ji TJ, Lee HY, Im IC. Usefulness of Liver fibrosis according to classification of image score system in abdominal ultrasonography. J Radiol. Sci. Technol. 2019 Jun;42(3):187-94. https://doi.org/10.17946/JRST.2019.42.3.187
  8. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007 Jul;56(7):968-73. https://doi.org/10.1136/gut.2006.111302
  9. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008 May;48(5):835-47. https://doi.org/10.1016/j.jhep.2008.02.008
  10. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. J Hepatol. 2007 Jul;46(1):32-6. https://doi.org/10.1002/hep.21669
  11. Sim SJ, Cheong JY, Cho SW, Kim JS, Lim TY, Shin DH, et al. Efficacy of AST to Platelet Ratio Index in Predicting Severe Hepatic Fibrosis and Cirrhosis in Chronic Hepatitis B Virus Infection. Korean J Gastroenterol. 2005 May;45(5):340-7.
  12. Park SY, Kang KH, Park JH, Lee JH, Cho CM, Tak WY, et al. Clinical efficacy of AST/ALT ratio and platelet counts as predictors of degree of fibrosis in HBV infected patients without clinically evident liver cirrhosis. Korean J Gastroenterol. 2004 Apr;43(4):246-51.
  13. Bae RC, Cho HJ, Oh JT, Lee EK, Heo J, Shin KY, et al. Clinical factors influencing liver stiffness as measured by transient elastography (Fibroscan) in patients with chronic liver disease. Korean J Hepatol. 2010 Jun;16(2):123-30. https://doi.org/10.3350/kjhep.2010.16.2.123
  14. Cheon HK, Lee TY, KIM YR. The Correlation of Sonographic Finding of Fatty Liver with Hematologic Examination and Body Fat Percentage. J Radiol. Sci. Technol. 2009 Dec;32(4):437-44.
  15. Zhu X, Wang LC, Chen EQ, Chen XB, Chen LY, Liu L, et al. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection. Dig Dis Sci. 2011 Sep;56(9):2742-9. https://doi.org/10.1007/s10620-011-1659-1
  16. Kim SE. Optimal Evaluation of the Results of Liver Function Tests. Korean J Med. 2019;94(1):89-95. https://doi.org/10.3904/kjm.2019.94.1.89